PATENTS
|
Patent
Number |
Issue
Date |
Issued
to |
Title |
|
US 7,115,556 |
10/3/2006 |
Oncolix |
Use of Anti-Prolactin Agents to Treat Proliferative Conditions |
1079851
Europe; Canada |
7/4/2007 |
Oncolix |
Use of Anti-Prolactin Agents to Treat Proliferative Conditions |
|
US 7,201,905 |
4/10/2007 |
Oncolix |
Bi-Functional Cancer Treatment
Agents |
|
US 7,339,027 |
3/4/2008 |
Oncolix |
Human Prolactin
Antagonist-Angiogenesis Inhibitor Fusion Proteins |
|
US 7,632,809 |
12/15/2009 |
Oncolix |
Multimeric Ligands with Enhanced
Stability |
| Patent Number |
Date
Filed |
Filed by |
Title |
|
US 11/073,927 |
3/8/2005 |
Oncolix |
Use of Prolactin Receptor Antagonists in Combination with an Agent that
Inactivates the HER2/neu Signaling Pathway |
|
US 61/155624 |
2/26/2009 |
Oncolix |
Compositions and Methods for Visualizing and Eliminating Cancer Stem
Cells |
Target Therapy
Monotherapy
Combination Therapy
| |
 |
